Live Breaking News & Updates on Yann mazabraud

Stay informed with the latest breaking news from Yann mazabraud on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Yann mazabraud and stay connected to the pulse of your community

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Rating Reaffirmed by Needham & Company LLC

Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Needham & Company LLC in a research report issued to clients and investors on Friday, Benzinga reports. They presently have a $50.00 price target on the stock. Needham & Company LLC’s price target would suggest a potential upside […]

Wellington , New-zealand-general- , New-zealand , Yann-mazabraud , Joseph-shulman , Analyst-recommendations-for-rhythm-pharmaceuticals , Needham-company , Wealth-management , Hennion-walsh-asset-management-inc , Rhythm-pharmaceuticals-inc , Virtu-financial , Goldman-sachs-group

Rhythm Pharmaceuticals (NASDAQ:RYTM) Shares Down 4.6%

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) fell 4.6% during trading on Monday . The company traded as low as $39.72 and last traded at $40.00. 109,342 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 656,650 shares. The stock had previously closed at $41.94. Wall Street […]

Yann-mazabraud , Joseph-shulman , Goldman-sachs-group , Rhythm-pharmaceuticals-company-profile , Hermes-inc , News-ratings-for-rhythm-pharmaceuticals-daily , Wells-fargo-company , Needham-company , Rhythm-pharmaceuticals-inc , Morgan-stanley , Rhythm-pharmaceuticals , Nasdaq

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript February 22, 2024 Rhythm Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.7 EPS, expectations were $-0.7. Rhythm Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies […]

Germany , Italy , Japan , France , United-states , Netherlands , Spain , Nagoya , Aichi , United-kingdom , Canada , French

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.7 EPS, expectations were $-0.7. Rhythm Pharmaceuticals, Inc.

Japan , Germany , United-states , France , Italy , Netherlands , Boston , Massachusetts , United-kingdom , Canada , Spain , Nagoya

Yann Mazabraud Sells 1,594 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Stock

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) EVP Yann Mazabraud sold 1,594 shares of the company’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $51.38, for a total value of $81,899.72. Following the completion of the transaction, the executive vice president now directly owns 7,702 […]

China , Chicago , Illinois , United-states , Yann-mazabraud , Quarter-for-rhythm-pharmaceuticals , Needham-company , Rhythm-pharmaceuticals-inc , Rhythm-pharmaceuticals , Rhythm-pharmaceuticals-price-performance , Wells-fargo-company , Chicago-partners-investment-group

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) EVP Sells $81,899.72 in Stock

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) EVP Yann Mazabraud sold 1,594 shares of the stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $51.38, for a total value of $81,899.72. Following the sale, the executive vice president now owns 7,702 shares of the company’s stock, […]

Chicago , Illinois , United-states , China , Yann-mazabraud , Morgan-stanley , Life-insurance-co , Hedge-funds-weigh-in-on-rhythm-pharmaceuticals , Chicago-partners-investment-group , Wells-fargo-company , Nasdaq , Needham-company

Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome

BOSTON, Feb. 07, 2024 -- Rhythm Pharmaceuticals, Inc. , a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare...

Canada , United-states , Boston , Massachusetts , Italy , United-kingdom , Italian , Adam-daley , David-connolly , Yann-mazabraud , Drug-administration , Nasdaq

Rhythm Pharmaceuticals Announces Completion of Screening

-- Phase 3 hypothalamic obesity top-line data expected in 1H2025 -- -- Positive reimbursement decision achieved for IMCIVREE® (setmelanotide) to treat...

Spain , United-kingdom , Boston , Massachusetts , United-states , David-meeker , Yann-mazabraud , David-connolly , Adam-daley , Nasdaq , Ministry-of-health , Rhythm-pharmaceuticals-inc

Rhythm Pharmaceuticals Announces Completion of Screening for Enrollment in Setmelanotide Phase 3 Hypothalamic Obesity Trial and Additional Updates

-- Phase 3 hypothalamic obesity top-line data expected in 1H2025 -- -- Positive reimbursement decision achieved for IMCIVREE® to treat patients with Bardet-Biedl syndrome and POMC/LEPR...

United-kingdom , United-states , Boston , Massachusetts , Spain , Adam-daley , Yann-mazabraud , David-connolly , David-meeker , Corporate-communications , United-kingdom-medicines-healthcare-products-regulatory-agency , Berry-company-public-relations

Rhythm Pharmaceuticals (RYTM) Provides Business Update

Rhythm Pharmaceuticals (RYTM) Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , United-states , Boston , Massachusetts , Spain , David-meeker , Yann-mazabraud , Rhythm-pharmaceuticals-inc , Head-of-international-at-rhythm , Nasdaq , European-union , Ministry-of-health